Diabetes Specialist Available to Discuss Insulin Delivery Technology

Newswise — Noted endocrinologist, Marc Sandberg, MD, is available to answer questions and talk with reporters about the implications of inhaled insulin in the context of the current state-of-the-art insulin delivery technologies. Scheduled to provide public comment at the United States Food and Drug Administration (FDA) September 8 Endocrinologic and Metabolic Drugs Advisory Committee meeting, Dr. Sandberg participated in early inhaled insulin clinical studies and plans to address the clinical considerations that need to be undertaken should inhaled insulin be approval for patients.

Dr. Sandberg is the Medical Director of the Diabetes Health Center at Hunterdon Medical Center in New Jersey and has 10 years of clinical endocrinology experience. He is current Chairperson for the Clinical Services Task Force of the New Jersey Diabetes Council and the President-Elect of the New Jersey Leadership Council of the American Diabetes Association. Dr. Sandberg has been recognized with distinction by the American Diabetes Association's National Committee for Quality Assurance Provider Recognition Program for the Provision of Quality Diabetes Care and was named as one of New Jersey Monthly Magazine's Top Docs in 2005.